Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -40.52% is 57% below its 5-year average of -25.74%, near the low end of its 5-year range (-40.52%–-7.30%).
As of the fiscal period ended Tuesday, June 30, 2026. 7.41% below its 12-month average of -37.73%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -40.52%.
RETURN ON INVESTED CAPITAL (ROIC)
-40.52%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-37.73%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-32.42%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-25.74%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-7.41%
CURRENT VS 3Y AVG
-24.97%
CURRENT VS 5Y AVG
-57.41%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.61%
median of 660 covered companies
CURRENT VS SECTOR MEDIAN
-20.55%
vs the sector median at left
Nautilus Biotechnolgy, Inc.
Market Cap
$249.23M
Return on Invested Capital (ROIC)
-40.52%
TTM Avg
-37.73%
3Y Avg
-32.42%
5Y Avg
-25.74%
Market Cap
$248.06M
Return on Invested Capital (ROIC)
-59.90%
TTM Avg
-142.39%
3Y Avg
-118.24%
5Y Avg
-103.50%
Market Cap
$246.67M
Return on Invested Capital (ROIC)
-701.55%
TTM Avg
-3723.51%
3Y Avg
-1911.77%
5Y Avg
-1278.48%
Market Cap
$242.35M
Return on Invested Capital (ROIC)
-1718.59%
TTM Avg
-749.70%
3Y Avg
-566.74%
5Y Avg
-409.31%
Market Cap
$243.62M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-8.11%
3Y Avg
-7.60%
5Y Avg
-6.24%
Market Cap
$240.98M
Return on Invested Capital (ROIC)
-7.08%
TTM Avg
-12.89%
3Y Avg
-21.42%
5Y Avg
-39.95%
Market Cap
$241.56M
Return on Invested Capital (ROIC)
-25.38%
TTM Avg
-99.58%
3Y Avg
-69.59%
5Y Avg
-61.10%
Market Cap
$256.22M
Return on Invested Capital (ROIC)
-43.69%
TTM Avg
-34.60%
3Y Avg
-35.16%
5Y Avg
-35.84%
Market Cap
$240.97M
Return on Invested Capital (ROIC)
-69.76%
TTM Avg
-64.00%
3Y Avg
-45.05%
5Y Avg
-31.07%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nautilus Biotechnolgy, Inc. (NAUT) | $249.23M | -40.52% | -37.73% | -32.42% | -25.74% |
| Invivyd, Inc. (IVVD)vs › | $248.06M | -59.90% | -142.39% | -118.24% | -103.50% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $246.67M | -701.55% | -3723.51% | -1911.77% | -1278.48% |
| Galectin Therapeutics Inc. (GALT)vs › | $242.35M | -1718.59% | -749.70% | -566.74% | -409.31% |
| Lifecore Biomedical, Inc. (LFCR)vs › | $243.62M | N/A | -8.11% | -7.60% | -6.24% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $240.98M | -7.08% | -12.89% | -21.42% | -39.95% |
| InflaRx N.V. (IFRX)vs › | $241.56M | -25.38% | -99.58% | -69.59% | -61.10% |
| Century Therapeutics, Inc. (IPSC)vs › | $256.22M | -43.69% | -34.60% | -35.16% | -35.84% |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $240.97M | -69.76% | -64.00% | -45.05% | -31.07% |
| Anika Therapeutics, Inc. (ANIK)vs › | $258.56M | -3.17% | -4.70% | -2.14% | -2.73% |
ROIC
-40.5%
ROE
-43.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -40.52% |
| 2026-03-31 | -37.84% |
| 2025-12-31 | -36.49% |
| 2025-09-30 | -37.20% |
| 2025-06-30 | -36.59% |
| 2025-03-31 | -35.85% |
| 2024-12-31 | -34.65% |
| 2024-09-30 | -32.46% |
| 2024-06-30 | -30.85% |
| 2024-03-31 | -28.52% |
| 2023-12-31 | -25.69% |
| 2023-09-30 | -23.41% |
| 2023-06-30 | -21.43% |
| 2023-03-31 | -19.43% |
| 2022-12-31 | -18.53% |
| 2022-09-30 | -18.17% |
| 2022-06-30 | -17.20% |
| 2022-03-31 | -15.36% |
| 2021-12-31 | -12.86% |
| 2021-09-30 | -10.23% |
| 2021-06-30 | -7.30% |
| 2021-03-31 | -28.88% |
| 2020-12-31 | -19.20% |
| 2020-09-30 | -7.15% |
| 2020-06-30 | -9036.14% |
| 2019-12-31 | -4.29% |
| 2019-09-30 | -75.74% |
